Topics
April 2012 | global Perspectives
Intravitreal Bevacizumab for Vitreous Hemorrhage Secondary to PDR
Andres Amaya Espinosa, MD; Gina Baron Mendoza, MD; Maria Alejandra Toro Millan, MD; and Natalia Camacho Espinosa, MD
March 2012 | global Perspectives
Treatment of Polypoidal Choroidal Vasculopathy
Individualized plans may be warranted, as the disease course can vary.
Won Ki Lee, MD
July 30, 2026
Spanish Researchers Show Photoswitchable Drug Candidates Restore Vision-Related Behaviors in Retinal Degeneration Models
July 28, 2026
CHMP Backs Roche’s Susvimo for Wet AMD, European Commission Decision Pending
July 27, 2026
Aravind Eye Care System, Alcon Launch Global Vitreoretinal Surgery Training Center in India
July 24, 2026
FDA Approves Outlook Therapeutics' Lytenava as First Ophthalmic Bevacizumab for Wet AMD
May/June 2026 Insert
Editorially Independent Content, Supported With Advertising From Astellas
Supported by Zeiss
Editorially independent supported by Abbvie and Regenxbio
May/June 2026 Supplement
Editorially independent content supported by advertising from Genentech
Free Print Subscription
Email Newsletter
Conference Calendar
